Rozanolixizumab in Generalized Myasthenia Gravis: Pooled Analysis of the Phase 3 MycarinG Study and Two Open-Label Extensions.
Journal of neuromuscular diseases(2025)
AI Read Science
Must-Reading Tree
Example

Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined